Third-generation SERMs may face uphill battle - PubMed

• PMID: 21060064
• DOI: 10.1093/jnci/djq477

Third-generation SERMs may face uphill battle

Charlie Schmidt. J Natl Cancer Inst. 2010.

Similar articles

• Tipping the balance for the primary prevention of breast cancer.

  Vogel VG. Vogel VG. J Natl Cancer Inst. 2010 Nov 17;102(22):1683-5. doi: 10.1093/jnci/djq435. Epub 2010 Nov 4. J Natl Cancer Inst. 2010. PMID: 21051657 No abstract available.

• Breast cancer incidence in the randomized PEARL trial of lasofoxifene in postmenopausal osteoporotic women.

  LaCroix AZ, Powles T, Osborne CK, Wolter K, Thompson JR, Thompson DD, Allred DC, Armstrong R, Cummings SR, Eastell R, Ensrud KE, Goss P, Lee A, Neven P, Reid DM, Curto M, Vukicevic S; PEARL Investigators. LaCroix AZ, et al. J Natl Cancer Inst. 2010 Nov 17;102(22):1706-15. doi: 10.1093/jnci/djq415. Epub 2010 Nov 4. J Natl Cancer Inst. 2010. PMID: 21051656 Clinical Trial.

• Another selective estrogen-receptor modulator for osteoporosis.

  Becker C. Becker C. N Engl J Med. 2010 Feb 25;362(8):752-4. doi: 10.1056/NEJMe0912847. N Engl J Med. 2010. PMID: 20181977 No abstract available.

• [Evidence of raloxifene on postmenopausal osteoporosis].

  Okano H. Okano H. Nihon Rinsho. 2007 Nov 28;65 Suppl 9:374-80. Nihon Rinsho. 2007. PMID: 18161135 Review. Japanese. No abstract available.

• Who will benefit from treatment with selective estrogen receptor modulators (SERMs)?

  Sambrook P. Sambrook P. Best Pract Res Clin Rheumatol. 2005 Dec;19(6):975-81. doi: 10.1016/j.berh.2005.06.007. Best Pract Res Clin Rheumatol. 2005. PMID: 16301191 Review.

Cited by

• Osteoporosis: A Review of Treatment Options.

  Tu KN, Lie JD, Wan CKV, Cameron M, Austel AG, Nguyen JK, Van K, Hyun D. Tu KN, et al. P T. 2018 Feb;43(2):92-104. P T. 2018. PMID: 29386866 Free PMC article.

• Cyclopia extracts act as ERα antagonists and ERβ agonists, in vitro and in vivo.

  Visser K, Mortimer M, Louw A. Visser K, et al. PLoS One. 2013 Nov 4;8(11):e79223. doi: 10.1371/journal.pone.0079223. eCollection 2013. PLoS One. 2013. PMID: 24223909 Free PMC article.

• Bazedoxifene: a review of its use in the treatment of postmenopausal osteoporosis.

  Duggan ST, McKeage K. Duggan ST, et al. Drugs. 2011 Nov 12;71(16):2193-212. doi: 10.2165/11207420-000000000-00000. Drugs. 2011. PMID: 22035517 Review.

• Molecular Mechanisms and Emerging Therapeutics for Osteoporosis.

  Noh JY, Yang Y, Jung H. Noh JY, et al. Int J Mol Sci. 2020 Oct 15;21(20):7623. doi: 10.3390/ijms21207623. Int J Mol Sci. 2020. PMID: 33076329 Free PMC article. Review.

• Soy and Health Update: Evaluation of the Clinical and Epidemiologic Literature.

  Messina M. Messina M. Nutrients. 2016 Nov 24;8(12):754. doi: 10.3390/nu8120754. Nutrients. 2016. PMID: 27886135 Free PMC article. Review.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Ovid Technologies, Inc.
  • Silverchair Information Systems

• Medical

  • MedlinePlus Health Information